Latest filing published 16 Jun 2022 for Pacira BioSciences, Inc., €220k.
Filing timeline
BuySaleInsider track record
Charles Anthony Laranjeira: trading record in brief
Charles Anthony Laranjeira discloses dealings in 2 companies, chiefly Pacira BioSciences, Inc. and Cubist Pharmaceuticals Inc. We count 39 filings; the first trade dates from 30 September 2011 and the latest from 14 June 2022.
Sales make up the whole of the open-market record (15 sales, €4.0M). Outside the open market, there are 5 share grants and 11 option exercises. 2022 to date brings no purchases and 5 sales.
The record was last updated on 16 June 2022 with an option exercise (€220k) in Pacira BioSciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Charles Anthony Laranjeira
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,000 shares@ US$38.3528.2% of flowCommon StockSEC:0001209191-22-037399:0
- 2,521 shares@ US$59.082.3% of flowCommon StockSEC:0001209191-22-035228:1
- 516 shares@ US$60.990.5% of flowCommon StockSEC:0001209191-22-035228:3
- 267 shares@ US$61.980.3% of flowCommon StockSEC:0001209191-22-035228:4
- 1,633 shares@ US$60.231.5% of flowCommon StockSEC:0001209191-22-035228:2
- 9,900 shares0Common StockSEC:0001209191-22-035228:5
- 2,813 shares@ US$61.37420.7% of flowCommon StockSEC:0001209191-22-035228:0
- 7,500 shares@ US$44.1037.5% of flowCommon StockSEC:0001209191-21-066795:0
- 7,000 shares0Common StockSEC:0001209191-21-040086:0
- 2,117 shares@ US$61.03713.6% of flowCommon StockSEC:0001209191-21-038881:0
- 2,500 shares@ US$44.101.6% of flowCommon StockSEC:0001209191-20-045200:0
- 2,500 shares@ US$52.681.9% of flowCommon StockSEC:0001209191-20-045200:1
- 15,000 shares@ US$38.358.8% of flowCommon StockSEC:0001209191-20-039976:1
- 7,500 shares@ US$43.545.0% of flowCommon StockSEC:0001209191-20-039976:2
- 30,000 shares@ US$44.1020.2% of flowCommon StockSEC:0001209191-20-039976:3
- 51,464 shares@ US$50.0139.4% of flowCommon StockSEC:0001209191-20-039976:4
- 6,859 shares@ US$51.775.4% of flowCommon StockSEC:0001209191-20-039976:5
- 1,778 shares@ US$52.031.4% of flowCommon StockSEC:0001209191-20-039976:6
- 3,750 shares@ US$37.812.2% of flowCommon StockSEC:0001209191-20-039976:0
- 14,000 shares0Common StockSEC:0001209191-20-036046:0
- 863 shares@ US$46.330.6% of flowCommon StockSEC:0001209191-20-035171:0
- 5,000 shares0Common StockSEC:0001209191-19-035098:1
- 430 shares@ US$42.910.3% of flowCommon StockSEC:0001209191-19-035098:0
- 5,000 shares0Common StockSEC:0001209191-18-038198:0
- 10,000 shares@ US$35.90Common StockSEC:0001127602-13-017834:0
25 of 39 declarations
